GLP-1 receptor agonists have established compelling evidence for the commercial value of multi-indication drug development beyond obesity. Conventional paradigms for drug development must shift in order to adapt to multi...
Press releases
-
Best Partnership award win from Pharma Times
ICON and Regeneron Win Best Partnership in Clinical Research Award from PharmaTimes
-
ICON named by Forbes as One of the Best Employers in America
Forbes ranking of top employers drawn from a survey of 30,000 US employees in 25 industry sectors
-
ICON awarded Best CRO at World Vaccine Congress 2017
ICON recognised for continually setting standards of excellence in vaccine development
-
ICON honoured as company of the year at the Business & Finance Irish Business Awards
Award recognises ICON’s business leadership, growth, innovation and employee development
-
ICON honoured as Contract Services Company at the Pharma Industry Awards
The Pharma Industry Awards celebrate the most original and innovative individuals and companies in the Irish Pharma sector.
-
ICON completes the acquisition of Clinical Research Management, Inc.
Acquisition extends ICON’s presence in the market for government sponsored research and enhances capabilities in Vaccines and Infectious Disease
-
ICON to Acquire Clinical Research Management, Inc.
ClinicalRM provide full service and functional research solutions to a broad range of US government agencies. -
ICON and Pfizer win Clinical Research Team of the Year
ICON and Pfizer Honoured as Clinical Research Team of the Year at the Clinical and Research Excellence Awards
-
ICON acquires PMG Research Inc.
Acquisition enhances ICON’s site and patient engagement capabilities
-
ICON and IBM to revolutionise clinical trials
ICON applies IBM Watson clinical trial matching to oncology clinical trials.
